Search - tctmd.com

Displaying 581 - 600 of 1104

Sort: Relevancy | Date

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Presentation TCT 2014

When Should Aspirin Be Dropped From Triple Therapy? Musings on Woest and Beyond

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Harvey D. White

September 15, 2014

Presentation TCT 2014

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Jonathan L. Halperin

September 15, 2014

News Conference News TCT 2014

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

September 15, 2014

News Industry News

CardioMEMS Data Shows Pulmonary Artery Pressure Monitoring Significantly Reduces Heart Failure Hospitalizations in Patients with Chronic Kidney Disease

September 15, 2014

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

Presentation TCT 2014

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Presenter: Dirk Sibbing

September 14, 2014

Presentation TCT 2014

Yes: TRA-2P Has Proven it!

Presenter: David J. Moliterno

September 14, 2014

Presentation TCT 2014

Integrating a WOEST Aspirin Deletion Strategy Into Clinical Practice: When Is it Appropriate?

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Freek W.A. Verheugt

September 14, 2014

Presentation TCT 2014

NO: Cangrelor Is No Champion Next to the Appropriate Use of Potent Oral Antiplatelet Agents!

Presenter: Dimitrios Alexopoulos

September 14, 2014

Presentation TCT 2014

YES: CHAMPION PHOENIX was Convincing!

Presenter: Deepak L. Bhatt

September 14, 2014

Presentation TCT 2014

Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well!

Presenter: Harvey D. White

September 14, 2014

Presentation TCT 2014

Featured Lecture: Aspirin, the Most Understood and Misunderstood Antiplatelet Agent

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Anthony A. Bavry

September 14, 2014

Presentation TCT 2014

Can LAA Closure Become the New Standard for Stroke Prevention?

Presenter: Hilary Nierenberg, Julie Logan, Saibal Kar

September 14, 2014

Presentation TCT 2014

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Lorenz Raber

September 14, 2014

Presentation TCT 2014

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Presenter: Paul A. Gurbel, Dmitriy N. Feldman

September 14, 2014

News Conference News TCT 2014

TCT Keynote: Global Vision for Prevention in Children and Adults Could Change CVD Landscape

September 14, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Daily News

就在接受PCI前的阿司匹林高反应性导致结果更差

September 02, 2014

Advertisement

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

When Should Aspirin Be Dropped From Triple Therapy? Musings on Woest and Beyond

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

CardioMEMS Data Shows Pulmonary Artery Pressure Monitoring Significantly Reduces Heart Failure Hospitalizations in Patients with Chronic Kidney Disease

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Yes: TRA-2P Has Proven it!

Integrating a WOEST Aspirin Deletion Strategy Into Clinical Practice: When Is it Appropriate?

NO: Cangrelor Is No Champion Next to the Appropriate Use of Potent Oral Antiplatelet Agents!

YES: CHAMPION PHOENIX was Convincing!

Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well!

Featured Lecture: Aspirin, the Most Understood and Misunderstood Antiplatelet Agent

Can LAA Closure Become the New Standard for Stroke Prevention?

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

TCT Keynote: Global Vision for Prevention in Children and Adults Could Change CVD Landscape

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

就在接受PCI前的阿司匹林高反应性导致结果更差

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content